Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.32 |
| ▸ | PNMT | P11086 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23716287 | 0.87 | ANO1 (0.34) | ANO1MAPTMAPK1PIK3CATRPA1 | |
| SCHEMBL23716186 | 0.87 | IDO1 (0.41) | PIK3CAPNMTTAAR1 | |
| SCHEMBL23715951 | 0.80 | GRM2 (0.34) | ANO1MAPTMAPK1PIK3CAGRM2 | |
| SCHEMBL23716188 | 0.79 | ANO1 (0.33) | ANO1MAPTMAPK1GRM2 | |
| SCHEMBL23716096 | 0.79 | IDO1 (0.37) | MAPTTAAR1 | |
| SCHEMBL23716112 | 0.77 | PIK3CA (0.43) | PIK3CATRPA1GRM2GRM3 | |
| SCHEMBL23715780 | 0.74 | IDO1 (0.42) | PIK3CAPNMTTAAR1 | |
| SCHEMBL23716046 | 0.73 | IDO1 (0.38) | MAPTTAAR1 | |
| SCHEMBL23715862 | 0.73 | IDO1 (0.41) | PIK3CAPNMTTAAR1 | |
| SCHEMBL27371624 | 0.72 | PNMT (0.39) | ANO1MAPTMAPK1PIK3CAGRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3209732-B1 | SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS | SCRIPPS RESEARCH INST (US) | 2021-08-04 | — | — | EP | disclosed |